GIRUS Life Sciences

GIRUS Life Sciences is a cell biology-based company dedicated to developing technologies that control biological outcomes in tissues and tissue cultures. The company's BioProcess division focuses on developing animal-free cell culture products and provides R&D services to accelerate drug development. The division's products include Regocel™ supplements, a new set of small molecule formulations that modulate cell viability, growth, and enhance the production of small, medium, and large cultures. The company’s product portfolio also includes GEMT and animal-free Regocel™ media for mammalian cells.